FDA Inspection
Asclemed USA Inc. dba Enovachem PharmaceuticalsAsclemed USA Inc. dba Enovachem Pharmaceuticals – FDA Inspection, Oct 12, 2017
Record Details
This FDA Inspection record concerns Asclemed USA Inc. dba Enovachem Pharmaceuticals, with an inspection on October 12, 2017, issued by the Los Angeles District Office, covering human drugs.
- Inspection Date
- October 12, 2017
- Product Type
- Human Drugs
View Company Profile
ID · 7f4c0a1a-1fbe-487e-99f1-159e81ab9865
Inspection Facts
- Inspection number
- 1029155
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.182Personnel dating/signing equipment log
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Asclemed USA Inc. dba Enovachem Pharmaceuticals
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 5, 2025 | Not classified | Los Angeles District Office | |
| November 5, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 27, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 15, 2015 | VAI | Center for Drug Evaluation and Research | Unapproved and Misbranded Drugs |
| April 18, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Asclemed USA Inc. dba Enovachem Pharmaceuticals
- FDA Inspection 1263548 - 2025-03-05
- FDA Inspection 1111700 - 2019-11-05
- FDA Inspection 1067059 - 2018-09-27
- FDA Inspection 937934 - 2015-07-15
- FDA Inspection 828037 - 2013-04-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.